Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      USFDA completes audit of Louisiana-based facility with no observations: Dr Reddys

      USFDA completes audit of Louisiana-based facility with no observations: Dr Reddys

      Farhat Nasim11 Aug 2019 9:48 AM IST
      As per the USFDA, Form 483 is issued to a firm's management at the conclusion of an inspection when the investigator has observed any conditions that...
      Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide

      Should Next Gen DES Stents be removed from Price Cap- Govt Panel to Decide

      Farhat Nasim10 Aug 2019 4:51 PM IST
      NEW DELHI: In a bid to re-enter the market with advanced drug-eluting stents (DES), various medical device makers are in talks with the Government to...
      Aurobindo Pharma Q1 net profit up by 39.52 percent to Rs 636 crore

      Aurobindo Pharma Q1 net profit up by 39.52 percent to Rs 636 crore

      Farhat Nasim8 Aug 2019 9:45 AM IST
      "We have started the year with a healthy performance. Enhancing our quality management practices and adhering to the regulatory requirements continues...
      Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

      Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

      Farhat Nasim8 Aug 2019 9:00 AM IST
      Puneet Srivastava will lead the Sales and Marketing function at a group level. Prior to joining Paras Healthcare, Srivastava was associated with the...
      Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

      Price Cap: NLEM Committe to now target intraocular lens, dialysis fluid, hearing aids;

      Farhat Nasim7 Aug 2019 5:30 PM IST
      New Delhi: After fixing the prices of various stents including cardiac stents and orthopaedic implants and even cancer drugs, the government is soon...
      Tech Giant Google collaborates with Doctors to help recognise diseases

      Tech Giant Google collaborates with Doctors to help recognise diseases

      Farhat Nasim7 Aug 2019 9:45 AM IST
      A student Claudius said there were chances that people might be misled into believing that they have dangerous diseases and would be prone to the...
      Fortis Healthcare reports profit of Rs 78 crore for June quarter

      Fortis Healthcare reports profit of Rs 78 crore for June quarter

      Farhat Nasim7 Aug 2019 9:16 AM IST
      Gross debt was reduced from Rs 1,657 crore in the first quarter of 2018-19 to Rs 1,388 crore in April-June 2019-20 reflecting a robust net debt to...
      Nestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75 premature infants: Govt asks ICMR to probe

      Nestle, 5 Top Hospitals Including Gangaram, Manipal under scanner over clinical trials on 75 premature infants: Govt asks ICMR to probe

      Farhat Nasim5 Aug 2019 3:55 PM IST
      New Delhi: Indian arm of Swiss food giant, Nestle has fallen under the Government's lens for allegedly sponsoring research in five Indian hospitals...
      NCLAT stays eviction of over Rs 9000 crore debt-ridden Sterling Biotech from its premises

      NCLAT stays eviction of over Rs 9000 crore debt-ridden Sterling Biotech from its premises

      Farhat Nasim5 Aug 2019 9:10 AM IST
      The appellate tribunal observed that although Sterling Biotech, which is presently going through liquidation, is not the owner of the premises it...
      Six bodies registered with CDSCO to audit medical device manufacturing sites as per new MD Rules

      Six bodies registered with CDSCO to audit medical device manufacturing sites as per new MD Rules

      Farhat Nasim4 Aug 2019 3:29 PM IST
      New Delhi: Through a recent public notice, the apex drug regulatory body, Central Drugs Standard Control Organisation(CDSCO) has notified six bodies...
      Sun Pharma sudden closure of Vadodara RnD units leaves around 85 employees in lurch

      Sun Pharma sudden closure of Vadodara RnD units leaves around 85 employees in lurch

      Farhat Nasim3 Aug 2019 3:26 PM IST
      Mumbai: In a move that will axe job of around 85 employees (as pegged my market sources), Dilip Shanghvi led Sun Pharmaceuticals Ltd. (Sun Pharma) has...
      Unichem Labs gets 4 USFDA observations for Goa formulation facility

      Unichem Labs gets 4 USFDA observations for Goa formulation facility

      Farhat Nasim3 Aug 2019 9:39 AM IST
      At the end of an inspection, the facility received four observations, with no repeat observations and are mostly procedural in nature, Unichem Labs...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok